PipelinePharma Logo

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Cetrorelix manufacturers

Filters

Filters

Filters , active

Country of origin : China

Clear all

None products found

cetrorelix

Injection 0.25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
CN
Manufacturer #12677
The company is a prominent pharmaceutical group established in 1971, dedicated to providing high-quality and effective healthcare products and services. With over 20 subsidiaries and more than 16,000 employees across major cities, the company emphasizes innovation and quality, operating four national R&D platforms. Recognized for its excellence, it has won multiple State Science and Technology Advancement Awards and holds international standards for Chinese medicinal materials included in the European Pharmacopoeia. The company focuses on quality-first and efficiency-priority principles, aiming to enhance health outcomes while continuously advancing in the global healthcare industry.

Manufacturer usually replies in 26 days

cetrorelix

Injection 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #30443

This company is a pharmaceutical supplier established in 2008, specializing in providing high-quality raw materials to the global market. They offer a wide range of products including Active Pharmaceutical Ingredients (APIs), excipients, intermediates, plant extracts, and finished formulation biological products. Their key therapy areas appear to include diabetes and dermatology, with APIs like Ciclopirox olamine, Halobetasol Propionate, Dapagliglozin, Sitagliptin phosphate, Vildagliptin, and Ketoprofen featured prominently. While specific dosage forms and GMP certifications are not mentioned, their extensive product portfolio suggests a focus on various formulations to cater to diverse pharmaceutical needs. They serve customers primarily in regions like North America, Europe, Japan, Korea, India, and Bangladesh.

cetrorelix

Injection 0.25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #29288

This hi-tech enterprise specializes in the research and manufacturing of diverse peptide products. Founded in 1998, it has become one of the leading peptide pharmaceutical companies globally, offering a full range of services including finished dosage products, APIs, and CRO/CMO services. Their finished dosage products are primarily sold domestically, while APIs have international distribution. The company operates a GMP-certified manufacturing facility exceeding 1500 sq. m., regularly inspected by local and international authorities. They focus on several key therapy areas, employing various principal dosage forms, including peptide-based formulations.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.